VALN
Valneva SE ADR
NASDAQ: VALN · HEALTHCARE · BIOTECHNOLOGY
$5.07
+0.20% today
Updated 2026-07-29
Market cap
$510.60M
P/E ratio
—
P/S ratio
3.27x
EPS (TTM)
$-1.82
Dividend yield
—
52W range
$5 – $12
Volume
0.0M
Valneva SE ADR (VALN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$5.07
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$6.14
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.3B | $0.4B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 9.62% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -88.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.